Orakl Oncology↗
AI trained on patient tumor organoids to speed up cancer drug development
$34M Series A · Nov 2026
Hires from TalentLetter
Growing thousands of patient tumor organoids to train AI on cancer drug response.
Florent, Karma DrivenRoles I picked6 picked among 10 open
Senior Data ScientistDefine the canonical data model and move lab data to the cloud at scale, working beside scientists and lab technicians.Apply
Senior Data EngineerDesign the omics data architecture from scratch, reporting to the Head of Computational Biology.Apply
Product Marketing LeadFirst product marketing hire, working directly with founders to take tumor-organoid AI to pharma.Apply
Senior Business Development ManagerShape how Orakl sells to pharma, and help structure the BD team.Apply
Alliance & Delivery Manager, Pharma PartnershipsCarry pharma partnerships from signature to final delivery, turning each contract into an executable research plan.Apply
Scientific Product Director, Clinical PredictionTurn tumor-organoid science into a product that derisks clinical drug development.Apply
